Clinical Trials Directory

Trials / Conditions / Vasoplegia

Vasoplegia

21 registered clinical trials studyying Vasoplegia — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingGENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Bio
NCT07345403
Medical University of Gdansk—
Not Yet RecruitingEffect Inhaled Nitric Oxide in Adult Liver Transplant
NCT07125443
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
RecruitingFemoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients
NCT06952907
Guillaume BESCHN/A
RecruitingReducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II
NCT06615102
Universität MünsterPhase 3
RecruitingCharacterisation of Endothelial Cells in Different Inflammatory Pathologies
NCT06613256
Royal Surrey County Hospital NHS Foundation Trust—
UnknownEndotoxinemia and Vasoplegia Following Cardiothoracic Surgery With Cardiopulmonary Bypass (CPB)
NCT05925348
Universität Münster—
RecruitingNorepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery
NCT05922982
Centre Hospitalier Universitaire, AmiensN/A
RecruitingDifferential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery
NCT05833828
Universität Münster—
Active Not RecruitingAngiotensin II in Liver Transplantation
NCT04901169
University of California, San FranciscoPhase 2 / Phase 3
CompletedReducing Acute Kidney Injury Occurence by Administering Angiotensin II
NCT05199493
Universität MünsterPhase 3
UnknownPrevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb
NCT04812717
Leiden University Medical CenterN/A
UnknownAssessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock
NCT04964492
Centre Hospitalier Universitaire, Amiens—
RecruitingMidodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)
NCT05058612
University of AlbertaPhase 4
UnknownLow Dose Corticosteroid Infusion in Vasoplegia After Cardiac Surgery (CORTIVAS-CS)
NCT04301479
Instituto do CoracaoPhase 3
WithdrawnHemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Sur
NCT03446599
Dartmouth-Hitchcock Medical CenterPhase 2
UnknownHypotension During Extracorporeal Circulatory Support Indicated for Cardiogenic Shock
NCT03968926
University Hospital, Montpellier—
CompletedImpact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery
NCT03744702
Mayo ClinicEARLY_Phase 1
CompletedAnalysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery
NCT05354193
University of Sao Paulo General Hospital—
CompletedEvaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue
NCT03120637
Institute of Liver and Biliary Sciences, IndiaPhase 4
UnknownEvaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During
NCT02965339
Centre Hospitalier Universitaire, Amiens—
UnknownPostoperative Hemodynamics Comparison After High Spinal Block With or Without Intrathecal Morphine.
NCT02825056
Post Graduate Institute of Medical Education and Research, ChandigarhEARLY_Phase 1